FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2938991280> ?p ?o ?g. }

• W2938991280 endingPage "846.e5" @default.
• W2938991280 startingPage "835" @default.
• W2938991280 abstract "Interleukin-38 (IL-38) is a cytokine of the IL-1 family with a role in chronic inflammation. However, its main cellular targets and receptors remain obscure. IL-38 is highly expressed in the skin and downregulated in psoriasis patients. We report an investigation in cellular targets of IL-38 during the progression of imiquimod-induced psoriasis. In this model, IL-38 knockout (IL-38 KO) mice show delayed disease resolution with exacerbated IL-17-mediated inflammation, which is reversed by the administration of mature IL-38 or γδ T cell-receptor-blocking antibodies. Mechanistically, X-linked IL-1 receptor accessory protein-like 1 (IL1RAPL1) is upregulated upon γδ T cell activation to feedforward-amplify IL-17 production and is required for IL-38 to suppress γδ T cell IL-17 production. Accordingly, psoriatic IL1RAPL1 KO mice show reduced inflammation and IL-17 production by γδ T cells. Our findings indicate a role for IL-38 in the regulation of γδ T cell activation through IL1RAPL1, with consequences for auto-inflammatory disease." @default.
• W2938991280 created "2019-04-25" @default.
• W2938991280 creator A5013203461 @default.
• W2938991280 creator A5017526919 @default.
• W2938991280 creator A5019558701 @default.
• W2938991280 creator A5028191617 @default.
• W2938991280 creator A5032227105 @default.
• W2938991280 creator A5032277582 @default.
• W2938991280 creator A5032343417 @default.
• W2938991280 creator A5036584822 @default.
• W2938991280 creator A5037907291 @default.
• W2938991280 creator A5041194504 @default.
• W2938991280 creator A5052181125 @default.
• W2938991280 creator A5052861559 @default.
• W2938991280 creator A5054989793 @default.
• W2938991280 creator A5056208745 @default.
• W2938991280 creator A5056936426 @default.
• W2938991280 creator A5059350207 @default.
• W2938991280 creator A5062822478 @default.
• W2938991280 creator A5082324344 @default.
• W2938991280 creator A5083507898 @default.
• W2938991280 creator A5086646466 @default.
• W2938991280 date "2019-04-01" @default.
• W2938991280 modified "2023-10-14" @default.
• W2938991280 title "IL-38 Ameliorates Skin Inflammation and Limits IL-17 Production from γδ T Cells" @default.
• W2938991280 cites W1939997832 @default.
• W2938991280 cites W1962133216 @default.
• W2938991280 cites W1999595280 @default.
• W2938991280 cites W1999807078 @default.
• W2938991280 cites W2007493851 @default.
• W2938991280 cites W2014913358 @default.
• W2938991280 cites W2019645050 @default.
• W2938991280 cites W2020466729 @default.
• W2938991280 cites W2029128580 @default.
• W2938991280 cites W2035880703 @default.
• W2938991280 cites W2045138888 @default.
• W2938991280 cites W2052943307 @default.
• W2938991280 cites W2059063061 @default.
• W2938991280 cites W2065688950 @default.
• W2938991280 cites W2066671159 @default.
• W2938991280 cites W2075039399 @default.
• W2938991280 cites W2094792719 @default.
• W2938991280 cites W2096637604 @default.
• W2938991280 cites W2099578672 @default.
• W2938991280 cites W2109666345 @default.
• W2938991280 cites W2114308202 @default.
• W2938991280 cites W2118258530 @default.
• W2938991280 cites W2121933593 @default.
• W2938991280 cites W2159513688 @default.
• W2938991280 cites W2188988854 @default.
• W2938991280 cites W2293688663 @default.
• W2938991280 cites W2536639665 @default.
• W2938991280 cites W2561759163 @default.
• W2938991280 cites W2586774552 @default.
• W2938991280 cites W2594840304 @default.
• W2938991280 cites W2595275031 @default.
• W2938991280 cites W2737765537 @default.
• W2938991280 cites W2772754327 @default.
• W2938991280 cites W2780744144 @default.
• W2938991280 cites W2793989315 @default.
• W2938991280 cites W2899084465 @default.
• W2938991280 doi "https://doi.org/10.1016/j.celrep.2019.03.082" @default.
• W2938991280 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30995480" @default.
• W2938991280 hasPublicationYear "2019" @default.
• W2938991280 type Work @default.
• W2938991280 sameAs 2938991280 @default.
• W2938991280 citedByCount "63" @default.
• W2938991280 countsByYear W29389912802019 @default.
• W2938991280 countsByYear W29389912802020 @default.
• W2938991280 countsByYear W29389912802021 @default.
• W2938991280 countsByYear W29389912802022 @default.
• W2938991280 countsByYear W29389912802023 @default.
• W2938991280 crossrefType "journal-article" @default.
• W2938991280 hasAuthorship W2938991280A5013203461 @default.
• W2938991280 hasAuthorship W2938991280A5017526919 @default.
• W2938991280 hasAuthorship W2938991280A5019558701 @default.
• W2938991280 hasAuthorship W2938991280A5028191617 @default.
• W2938991280 hasAuthorship W2938991280A5032227105 @default.
• W2938991280 hasAuthorship W2938991280A5032277582 @default.
• W2938991280 hasAuthorship W2938991280A5032343417 @default.
• W2938991280 hasAuthorship W2938991280A5036584822 @default.
• W2938991280 hasAuthorship W2938991280A5037907291 @default.
• W2938991280 hasAuthorship W2938991280A5041194504 @default.
• W2938991280 hasAuthorship W2938991280A5052181125 @default.
• W2938991280 hasAuthorship W2938991280A5052861559 @default.
• W2938991280 hasAuthorship W2938991280A5054989793 @default.
• W2938991280 hasAuthorship W2938991280A5056208745 @default.
• W2938991280 hasAuthorship W2938991280A5056936426 @default.
• W2938991280 hasAuthorship W2938991280A5059350207 @default.
• W2938991280 hasAuthorship W2938991280A5062822478 @default.
• W2938991280 hasAuthorship W2938991280A5082324344 @default.
• W2938991280 hasAuthorship W2938991280A5083507898 @default.
• W2938991280 hasAuthorship W2938991280A5086646466 @default.
• W2938991280 hasBestOaLocation W29389912801 @default.
• W2938991280 hasConcept C104317684 @default.
• W2938991280 hasConcept C11988809 @default.
• W2938991280 hasConcept C126322002 @default.
• W2938991280 hasConcept C127561419 @default.

• next